Drugs News and Research

RSS

Tailored doses of pre-transplant drug therapy in Glaucomatous patients boosts survival rates to over 90%

Chronic Granulomatous Disease is a rare immune deficiency that seriously compromises organ function and is life-threatening, with 20-30 per cent of patients dying within the first two decades of life.

13 Nov 2013

Merck Serono signs co-development and commercialization agreement for BeiGene-290

Merck Serono, the biopharmaceutical division of Merck, today announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co., Ltd., a biotech research and development company in Beijing, China.

13 Nov 2013

Teen athletes more likely to misuse opioids medications

Teen athletes derive many positive benefits from participating in sports, but their increased risk of sports-related injuries may also heighten their risk for medication misuse and abuse, especially for boys, finds a recent study in the Journal of Adolescent Health.

13 Nov 2013

Using morphine to fight surgical pain may prolong patient's suffering

Using morphine to fight the pain associated with abdominal surgery may paradoxically prolong a patient's suffering, doubling or even tripling the amount of time it takes to recover from the surgical pain, according to researchers at the University of Colorado Boulder.

13 Nov 2013

Study outlines “sobering reality” of the U.S. health care system

Over the last decade, the biggest driver of the high health care costs in the United States has been neither the aging of the population nor the large numbers of tests and treatments being prescribed.

13 Nov 2013

People suffering from chronic pain, emotional distress likely to receive long-term opioid therapy

People suffering from chronic non-cancer pain and severe emotional distress, such as depression, anxiety and substance use, are likely to receive long-term opioid therapy despite a lack of evidence that this treatment helps, reports a new review in General Hospital Psychiatry.

13 Nov 2013

New view can give scientists better understanding of how antidepressants work in human brain

Research from Oregon Health & Science University's Vollum Institute, published in the current issue of Nature, is giving scientists a never-before-seen view of how nerve cells communicate with each other.

13 Nov 2013

Studies suggest novel therapies for nicotine, heroin and gambling addiction

Studies released today suggest promising new treatments for nicotine and heroin addiction, and further our understanding of pathological gambling and heroin abuse in those suffering chronic pain.

12 Nov 2013

Furamidine drug may also be useful in treating cancers, immune-related diseases

A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.

12 Nov 2013

Hebrew University to participate in new European research project on chronic pain

The Hebrew University of Jerusalem is one of 11 universities, medical centers and research institutes in seven countries participating in ncRNAPain, a new European research project that aims at further exploring the biological mechanisms underlying chronic pain.

12 Nov 2013

Nontoxic therapy shows encouraging results in blood samples from lupus patients

Northwestern Medicine- scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease.

12 Nov 2013

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Swiss-based Helsinn group has granted Chugai Pharma Marketing Ltd., a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd., exclusive commercialization rights to their innovative ghrelin receptor agonist, anamorelin, for the three major European pharma markets.

12 Nov 2013

Researchers develop model that predicts earlier prediction of Alzheimer's disease in older adults

Using scores obtained from cognitive tests, Johns Hopkins researchers think they have developed a model that could help determine whether memory loss in older adults is benign or a stop on the way to Alzheimer's disease.

12 Nov 2013

Study gives new insight into geographic variation in drug poisoning mortality in U.S

A new study published in the American Journal of Preventive Medicine gives new insight into the geographic variation in drug poisoning mortality, with both urban centers and rural areas showing a large increase in death rates.

12 Nov 2013

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant.

12 Nov 2013

Calcium-channel blocker and antibiotic intake linked with small but greater risk of kidney injury

Among older adults taking a calcium-channel blocker, simultaneous use of the antibiotic clarithromycin, compared with azithromycin, was associated with a small but statistically significant greater 30-day risk of hospitalization with acute kidney injury, according to a study published by JAMA. The study is being published early online to coincide with its presentation at the American Society of Nephrology's Kidney Week 2013.

12 Nov 2013

Researchers discovers key genetic culprit responsible for growth, metastasis of colon cancer

Chronic inflammation has long been known as a key risk factor for cancer---particularly colon cancer---but the exact mechanisms of how inflammation heightens the immune response, and ultimately influences the initiation and progression of cancer have remained elusive.

12 Nov 2013

Drugs News and Research

Tailored doses of pre-transplant drug therapy in Glaucomatous patients boosts survival rates to over 90%

Merck Serono signs co-development and commercialization agreement for BeiGene-290

Teen athletes more likely to misuse opioids medications

Using morphine to fight surgical pain may prolong patient's suffering

Study outlines “sobering reality” of the U.S. health care system

People suffering from chronic pain, emotional distress likely to receive long-term opioid therapy

New view can give scientists better understanding of how antidepressants work in human brain

Studies suggest novel therapies for nicotine, heroin and gambling addiction

Furamidine drug may also be useful in treating cancers, immune-related diseases

Hebrew University to participate in new European research project on chronic pain

Nontoxic therapy shows encouraging results in blood samples from lupus patients

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Researchers develop model that predicts earlier prediction of Alzheimer's disease in older adults

Study gives new insight into geographic variation in drug poisoning mortality in U.S

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Calcium-channel blocker and antibiotic intake linked with small but greater risk of kidney injury

Researchers discovers key genetic culprit responsible for growth, metastasis of colon cancer

FDA proposes change in generic drug makers' labels

Georgia University scientists identify cause of muscle weakness disease myasthenia gravis

Study shows that different brain regions process different types of fear

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News